司太立:北京金诚同达律师事务所关于浙江司太立制药股份有限公司重大资产购买暨关联交易的补充法律意见书2018-11-10
2018 1107 0473
1 100004
010-5706 8585 010-8515 0267
2018 1107 0473
“
”
2018 10 26
2018 11 7
2018 2614
1
”
4 2018 1-6 Dratig
Pharma Co.,Limited 2017
Nagase & Co.Ltd 1.18 2018 1925
1
2 Dratig Pharma Co.,Limited
Dratig Pharma Co.,Limited
1 Dratig Pharma Co.,Limited
Dratig Pharma Co., Limited Dratig Pharma
Dratig Pharma
2
100%
Dratig Pharma Co., Limited
2 Dratig Pharma
1 5%
2018 9 30 5%
1 2,565.00 21.38%
2 2,250.00 18.75%
3 1,210.00 10.08%
4 450.00 3.75%
5 270.00 2.25%
2
8,291.2659 82.91%
588.0000 5.88%
588.0000 5.88%
179.7930 1.80%
352.9411 3.53%
10,000.0000 100%
3 Dratig Pharma
3
Dratig Pharma
Dratig Pharma
Dratig Pharma
5%
4